Global haemostasis assays, from bench to bedside

Thrombosis Research

Volumn 129, Issue 6, 2012, Pages 681-687

  Van Geffen, Mark ^a   Van Heerde, Waander L ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

endogenous thrombin potential; fibrinolysis; haemostasis; max 5; thrombin generation test

Indexed keywords

ANTIVITAMIN K; COUMARIN DERIVATIVE; FONDAPARINUX; PHOSPHOLIPID; PLASMIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 8; THROMBIN; THROMBOPLASTIN;

BLEEDING TENDENCY; BLOOD CLOTTING DISORDER; CLINICAL PRACTICE; FIBRIN CLOT; FIBRINOLYSIS; FLUORESCENCE; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SCREENING; THROMBOELASTOGRAPHY; TURBIDITY;

BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; FIBRINOLYSIN; FIBRINOLYSIS; HEMOSTASIS; HUMANS; THROMBELASTOGRAPHY; THROMBIN;

EID: 84861330555     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.12.006     Document Type: Review

References (89)

1. H. ten Cate, K.A. Bauer, M. Levi, T.S. Edgington, R.D. Sublett, and S. Barzegar The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor J Clin Invest 92 3 Sep 1993 1207 1212
2. M. Levi The imbalance between tissue factor and tissue factor pathway inhibitor in sepsis Crit Care Med 30 8 Aug 2002 1914 1915
3. M. Levi, C.E. Hack, J.P. de Boer, D.P. Brandjes, H.R. Buller, and J.W. ten Cate Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo J Clin Invest 88 4 Oct 1991 1155 1160
4. C. Maas, J.C. Meijers, J.A. Marquart, K. Bakhtiari, C. Weeterings, and P.G. de Groot Activated factor V is a cofactor for the activation of factor XI by thrombin in plasma Proc Natl Acad Sci U S A 107 20 May 18 2010 9083 9087
5. P.A. von dem Borne, J.C. Meijers, and B.N. Bouma Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis Blood 86 8 Oct 15 1995 3035 3042
6. R.G. MacFarlane, and R. Biggs A thrombin generation test; the application in haemophilia and thrombocytopenia J Clin Pathol 6 1 Feb 1953 3 8
7. W.R. Pitney, and J.V. Dacie A simple method of studying the generation of thrombin in recalcified plasma; application in the investigation of haemophilia J Clin Pathol 6 1 Feb 1953 9 14
8. R. Biggs, and A.S. Douglas The thromboplastin generation test J Clin Pathol 6 1 Feb 1953 23 29
9. K.M. Brinkhous A study of the clotting defect in hemophilia: the delated formation of thrombin Am J Med Sci 198 4 1939 509 515
10. F.K. Herbert The estimation of prothrombin in human plasma Biochem J 34 12 Dec 1940 1554 1568
11. H.C. Hemker, S. Wielders, H. Kessels, and S. Beguin Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential Thromb Haemost 70 4 Oct 18 1993 617 624
12. H.C. Hemker, E. de Smedt, and R. Al Dieri The contribution of alpha(2)-macroglobulin thrombin to the endogenous thrombin potential Br J Haematol 139 3 Nov 2007 513
13. R.J. Wagenvoord, J. Deinum, M. Elg, and H.C. Hemker The paradoxical stimulation by a reversible thrombin inhibitor of thrombin generation in plasma measured with thrombinography is caused by alpha(2)-macroglobulin-thrombin J Thromb Haemost 8 6 Jun 2010 1281 1289
14. D.T. Rijkers, S.J. Wielders, S. Beguin, and H.C. Hemker Prevention of the influence of fibrin and alpha2-macroglobulin in the continuous measurement of the thrombin potential: implications for an endpoint determination of the optical density Thromb Res 89 4 Feb 15 1998 161 169
15. L. Svendsen, B. Blomback, M. Blomback, and P.I. Olsson Substrates for determination of trypsin, thrombin and thrombin-like enzymes Folia Haematol Int Mag Klin Morphol Blutforsch 98 4 1972 446 454
16. D.T. Rijkers, S.J. Wielders, G.I. Tesser, and H.C. Hemker Design and synthesis of thrombin substrates with modified kinetic parameters Thromb Res 79 5-6 Sep 15 1995 491 499
17. I.M. Keularts, A. Zivelin, U. Seligsohn, H.C. Hemker, and S. Beguin The role of factor XI in thrombin generation induced by low concentrations of tissue factor Thromb Haemost 85 6 Jun 2001 1060 1065
18. G.A. Mitchell, P.M. Hudson, R.M. Huseby, S.P. Pochron, and R.J. Gargiulo Fluorescent substrate assay for antithrombin III Thromb Res 12 2 Feb 1978 219 225
19. G.A. Mitchell, R.J. Garguilo, R.M. Huseby, D.E. Lawson, S.P. Pochron, and J.A. Sehuanes Assay for plasma heparin using a synthetic peptide substrate for thrombin: introduction of the fluorophore aminoisophthalic acid, dimethyl ester Thromb Res 13 1 Jul 1978 47 52
20. S.P. Leytus, L.L. Melhado, and W.F. Mangel Rhodamine-based compounds as fluorogenic substrates for serine proteinases Biochem J 209 2 Feb 1 1983 299 307
21. E. Sato, A. Matsuhisa, M. Sakashita, and Y. Kanaoka New water-soluble fluorogenic amine. 7-Aminocoumarin-4-methanesulfonic acid (ACMS) and related substrates for proteinases Chem Pharm Bull(Tokyo) 36 9 Sep 1988 3496 3502
22. H.C. Hemker, P.L. Giesen, M. Ramjee, R. Wagenvoord, and S. Beguin The thrombogram: monitoring thrombin generation in platelet-rich plasma Thromb Haemost 83 4 Apr 2000 589 591
23. S.P. Srinivas, and R. Mutharasan Inner filter effects and their interferences in the interpretation of culture fluorescence Biotechnol Bioeng 30 6 Oct 20 1987 769 774
24. R.R. Hantgan, and J. Hermans Assembly of fibrin. A light scattering study J Biol Chem 254 22 Nov 25 1979 11272 11281
25. M.E. Carr Jr., L.L. Shen, and J. Hermans Mass-length ratio of fibrin fibers from gel permeation and light scattering Biopolymers 16 1 Jan 1977 1 15
26. M.E. Carr Jr., D.A. Gabriel, and J. McDonagh Influence of Ca2+ on the structure of reptilase-derived and thrombin-derived fibrin gels Biochem J 239 3 Nov 1 1986 513 516
27. O.M. Theusinger, W. Baulig, L.M. Asmis, B. Seifert, and D.R. Spahn In vitro factor XIII supplementation increases clot firmness in Rotation Thromboelastometry (ROTEM) Thromb Haemost 104 2 Aug 2010 385 391
28. J.W. Weisel Structure of fibrin: impact on clot stability J Thromb Haemost 5 Suppl. 1 Jul 2007 116 124
29. J.W. Weisel Stressed fibrin lysis J Thromb Haemost 9 5 May 2011 977 978
30. B. Blomback, K. Carlsson, K. Fatah, B. Hessel, and R. Procyk Fibrin in human plasma: gel architectures governed by rate and nature of fibrinogen activation Thromb Res 75 5 Sep 1 1994 521 538
31. B. Blomback, K. Carlsson, B. Hessel, A. Liljeborg, R. Procyk, and N. Aslund Native fibrin gel networks observed by 3D microscopy, permeation and turbidity Biochim Biophys Acta 997 1-2 Jul 27 1989 96 110
32. D.A. Gabriel, K. Muga, and E.M. Boothroyd The effect of fibrin structure on fibrinolysis J Biol Chem 267 34 Dec 5 1992 24259 24263
33. S. He, K. Bremme, and M. Blomback A laboratory method for determination of overall haemostatic potential in plasma. I. Method design and preliminary results Thromb Res 96 2 Oct 15 1999 145 156
34. S. He, A. Antovic, and M. Blomback A simple and rapid laboratory method for determination of haemostasis potential in plasma. II. Modifications for use in routine laboratories and research work Thromb Res 103 5 Sep 1 2001 355 361
35. N.A. Goldenberg, W.E. Hathaway, L. Jacobson, and M.J. Manco-Johnson A new global assay of coagulation and fibrinolysis Thromb Res 116 4 2005 345 356
36. R.J. Luddington Thrombelastography/thromboelastometry Clin Lab Haematol 27 2 Apr 2005 81 90
37. M. Chitlur, B. Sorensen, G.E. Rivard, G. Young, J. Ingerslev, and M. Othman Standardization of thromboelastography: a report from the TEG-ROTEM working group Haemophilia 17 3 May 2011 532 537
38. M.T. Ganter, and C.K. Hofer Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices Anesth Analg 106 5 May 2008 1366 1375
39. L. Zuckerman, E. Cohen, J.P. Vagher, E. Woodward, and J.A. Caprini Comparison of thrombelastography with common coagulation tests Thromb Haemost 46 4 Dec 23 1981 752 756
40. G.E. Rivard, K.E. Brummel-Ziedins, K.G. Mann, L. Fan, A. Hofer, and E. Cohen Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography J Thromb Haemost 3 9 Sep 2005 2039 2043
41. K.E. Brummel, S.G. Paradis, S. Butenas, and K.G. Mann Thrombin functions during tissue factor-induced blood coagulation Blood 100 1 Jul 1 2002 148 152
42. J. O'Donnell, A. Riddell, D. Owens, A. Handa, J. Pasi, and G. Hamilton Role of the Thrombelastograph as an adjunctive test in thrombophilia screening Blood Coagul Fibrinolysis 15 3 Apr 2004 207 211
43. B. Sorensen, and J. Ingerslev Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa J Thromb Haemost 2 1 Jan 2004 102 110
44. A. Yoshioka, K. Nishio, and M. Shima Thrombelastgram as a hemostatic monitor during recombinant factor VIIa treatment in hemophilia A patients with inhibitor to factor VIII Haemostasis 26 Suppl. 1 1996 139 142
45. B.D. Spiess, B.S. Gillies, W. Chandler, and E. Verrier Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients J Cardiothorac Vasc Anesth 9 2 Apr 1995 168 173
46. L. Shore-Lesserson, H.E. Manspeizer, M. DePerio, S. Francis, F. Vela-Cantos, and M.A. Ergin Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery Anesth Analg 88 2 Feb 1999 312 319
47. Y.G. Kang, D.J. Martin, J. Marquez, J.H. Lewis, F.A. Bontempo, and B.W. Shaw Jr. Intraoperative changes in blood coagulation and thrombelastographic monitoring in liver transplantation Anesth Analg 64 9 Sep 1985 888 896
48. E. Kowalski, M. Kopec, and S. Niewiarowski An evaluation of the euglobulin method for the determination of fibrinolysis J Clin Pathol 12 3 May 1959 215 218
49. T. Urano, T. Nishikawa, N. Nagai, Y. Takada, and A. Takada Amounts of tPA and PAI-1 in the euglobulin fraction obtained at different pH: their relation to the euglobulin clot lysis time Thromb Res 88 1 Oct 1 1997 75 80
50. M. Ranby, I.B. Sundell, and T.K. Nilsson Blood collection in strong acidic citrate anticoagulant used in a study of dietary influence on basal tPA activity Thromb Haemost 62 3 Nov 24 1989 917 922
51. D.C. Rijken, N.E. Hoegee-de, A.F. Jie, D.E. Atsma, M.J. Schalij, and W. Nieuwenhuizen Development of a new test for the global fibrinolytic capacity in whole blood J Thromb Haemost 6 1 Jan 2008 151 157
52. M.L. Simpson, N.A. Goldenberg, L.J. Jacobson, C.G. Bombardier, W.E. Hathaway, and M.J. Manco-Johnson Simultaneous thrombin and plasmin generation capacities in normal and abnormal states of coagulation and fibrinolysis in children and adults Thromb Res 127 4 Apr 2011 317 323
53. M. van Geffen, A. Loof, P. Lap, J. Boezeman, B.A.P. Laros-van Gorkom, and B. Verbruggen A novel hemostasis assay for the simultaneous measurement of coagulation and fibrinolysis Hematology 16 6 May 23 2011 327 336
54. Y. Veklich, C.W. Francis, J. White, and J.W. Weisel Structural studies of fibrinolysis by electron microscopy Blood 92 12 Dec 15 1998 4721 4729
55. G.J. Broze Jr., and D.A. Higuchi Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma Blood 88 10 Nov 15 1996 3815 3823
56. J. Leurs, V. Nerme, Y. Sim, and D. Hendriks Carboxypeptidase U (TAFIa) prevents lysis from proceeding into the propagation phase through a threshold-dependent mechanism J Thromb Haemost 2 3 Mar 2004 416 423
57. J.B. Walker, and L. Bajzar The intrinsic threshold of the fibrinolytic system is modulated by basic carboxypeptidases, but the magnitude of the antifibrinolytic effect of activated thrombin-activable fibrinolysis inhibitor is masked by its instability J Biol Chem 279 27 Jul 2 2004 27896 27904
58. M.K. Ramjee The use of fluorogenic substrates to monitor thrombin generation for the analysis of plasma and whole blood coagulation Anal Biochem 277 1 Jan 1 2000 11 18
59. K. Lo, and S.L. Diamond Blood coagulation kinetics: high throughput method for real-time reaction monitoring Thromb Haemost 92 4 Oct 2004 874 882
60. Hemker HC, Beguin S, Al-Dieri R, Wagenvoord R, Nijhuis S, Giesen P. Measuring thrombin activity in whole blood. European Patent 1875249B1 2006.
61. R. Al Dieri, F. Peyvandi, E. Santagostino, M. Giansily, P.M. Mannucci, and J.F. Schved The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding Thromb Haemost 88 4 Oct 2002 576 582
62. T. Siegemund, S. Petros, A. Siegemund, U. Scholz, and L. Engelmann Thrombin generation in severe haemophilia A and B: the endogenous thrombin potential in platelet-rich plasma Thromb Haemost 90 5 Nov 2003 781 786
63. V.G. Nielsen, B.M. Cohen, and E. Cohen Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII Acta Anaesthesiol Scand 49 2 Feb 2005 222 231
64. S.J. Lewis, E. Stephens, G. Florou, N.J. Macartney, L.S. Hathaway, and J. Knipping Measurement of global haemostasis in severe haemophilia A following factor VIII infusion Br J Haematol 138 6 Sep 2007 775 782
65. T. Livnat, U. Martinowitz, A. Zivelin, D. Rima, and G. Kenet A highly sensitive thrombin generation assay for assessment of recombinant activated factor VII therapy in haemophilia patients with an inhibitor Thromb Haemost 105 4 Apr 2011 688 695
66. S. Eichinger, B. Lubsczyk, M. Kollars, L. Traby, K. Zwiauer, and A. Gleiss Thrombin generation in haemophilia A patients with factor VIII inhibitors after infusion of recombinant factor VIIa Eur J Clin Invest 39 8 Aug 2009 707 713
67. J. Duchemin, J.L. Pittet, M. Tartary, S. Beguin, P. Gaussem, and M. henc-Gelas A new assay based on thrombin generation inhibition to detect both protein C and protein S deficiencies in plasma Thromb Haemost 71 3 Mar 1994 331 338
68. N. Hezard, L. Bouaziz-Borgi, M.G. Remy, B. Florent, and P. Nguyen Protein C deficiency screening using a thrombin-generation assay Thromb Haemost 97 1 Jan 2007 165 166
69. N. Hezard, L. Bouaziz-Borgi, M.G. Remy, and P. Nguyen Utility of thrombin-generation assay in the screening of factor V G1691A (Leiden) and prothrombin G20210A mutations and protein S deficiency Clin Chem 52 4 Apr 2006 665 670
70. L.F. Lincz, A. Lonergan, F.E. Scorgie, P. Rowlings, R. Gibson, and A. Lawrie Endogenous thrombin potential for predicting risk of venous thromboembolism in carriers of factor V Leiden Pathophysiol Haemost Thromb 35 6 2006 435 439
71. V. Regnault, H.C. Hemker, D. Wahl, and T. Lecompte Phenotyping the haemostatic system by thrombography-potential for the estimation of thrombotic risk Thromb Res 114 5-6 2004 539 545
72. J. Curvers, M.C. Thomassen, J. Rimmer, K. Hamulyak, M.J. van der, and G. Tans Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test Thromb Haemost 88 1 Jul 2002 5 11
73. J. Ingerslev, K. Christiansen, A. Calatzis, M. Holm, and E.L. Sabroe Management and monitoring of recombinant activated factor VII Blood Coagul Fibrinolysis 11 Suppl. 1 Apr 2000 S25 S30
74. T. Hayashi, I. Tanaka, M. Shima, K. Yoshida, K. Fukuda, and Y. Sakurai Unresponsiveness to factor VIII inhibitor bypassing agents during haemostatic treatment for life-threatening massive bleeding in a patient with haemophilia A and a high responding inhibitor Haemophilia 10 4 Jul 2004 397 400
75. M.M. Samama, F.L. Le, C. Guinet, G. Gerotziafas, and F. Depasse Three different patterns of calibrated automated thrombogram obtained with six different anticoagulant J Thromb Haemost 5 12 Dec 2007 2554 2556
76. J. Hirsh, J.E. Dalen, D.R. Anderson, L. Poller, H. Bussey, and J. Ansell Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range Chest 114 5 Suppl. Nov 1998 445S 469S
77. R. Altman, A. Scazziota, J. Rouvier, and C. Gonzalez Effect of sodium arachidonate on thrombin generation through platelet activation-inhibitory effect of aspirin Thromb Haemost 84 6 Dec 2000 1109 1112
78. J.P. Herault, F. Dol, C. Gaich, A. Bernat, and J.M. Herbert Effect of clopidogrel on thrombin generation in platelet-rich plasma in the rat Thromb Haemost 81 6 Jun 1999 957 960
79. I.M. Keularts, S. Beguin, Z.C. de, and H.C. Hemker Treatment with a GPIIb/IIIa antagonist inhibits thrombin generation in platelet rich plasma from patients Thromb Haemost 80 3 Sep 1998 370 371
80. A.K. Rao, L. Sun, Y. Hiramatsu, J.H. Gorman III, and L.H. Edmunds Jr. Glycoprotein IIb/IIIa receptor antagonist tirofiban inhibits thrombin generation during cardiopulmonary bypass in baboons Thromb Haemost 82 1 Jul 1999 140 144
81. J.C. Reverter, S. Beguin, H. Kessels, R. Kumar, H.C. Hemker, and B.S. Coller Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis" J Clin Invest 98 3 Aug 1 1996 863 874
82. P. von Lode Point-of-care immunotesting: approaching the analytical performance of central laboratory methods Clin Biochem 38 7 Jul 2005 591 606
83. M.K. Runyon, B.L. Johnson-Kerner, and R.F. Ismagilov Minimal functional model of hemostasis in a biomimetic microfluidic system Angew Chem Int Ed Engl 43 12 Mar 12 2004 1531 1536
84. M.K. Runyon, B.L. Johnson-Kerner, C.J. Kastrup, T.G. Van Ha, and R.F. Ismagilov Propagation of blood clotting in the complex biochemical network of hemostasis is described by a simple mechanism J Am Chem Soc 129 22 Jun 6 2007 7014 7015
85. M.K. Runyon, C.J. Kastrup, B.L. Johnson-Kerner, T.G. Ha, and R.F. Ismagilov Effects of shear rate on propagation of blood clotting determined using microfluidics and numerical simulations J Am Chem Soc 130 11 Mar 19 2008 3458 3464
86. H. Song, H.W. Li, M.S. Munson, T.G. Van Ha, and R.F. Ismagilov On-chip titration of an anticoagulant argatroban and determination of the clotting time within whole blood or plasma using a plug-based microfluidic system Anal Chem 78 14 Jul 15 2006 4839 4849
87. H.M. Evans, E. Surenjav, C. Priest, S. Herminghaus, R. Seemann, and T. Pfohl In situ formation, manipulation, and imaging of droplet-encapsulated fibrin networks Lab Chip 9 13 Jul 7 2009 1933 1941
88. C. Thürlemann, A. Haeberli, and L. Alberio Monitoring thrombin generation by electrochemistry: development of an amperometric biosensor screening test for plasma and whole blood Clin Chem 55 3 Mar 2009 505 512
89. Thürlemann C. Entwicklung eines Biosensor-Systems für ein Patienten-Selbstmanagement der Behandlung mit Vitamin K-Antagonisten. http://pages.unibas.ch/diss/2005/DissB-7319.htm. [Dissertation] Basel (Switzerland): University of Basel; 2005, 1-181.